Passer au contenu

Enabling faster, more accessible molecular diagnostics

Actualités du groupe
Publications
Se connecter
Français
- English
- Français
Infections Respiratoires
Infections Gastro-intestinales
Résistances aux Antibiotiques
Infections Nosocomiales
Sepsis
Solution Coronavirus
Amplidiag® RESP-4
Novodiag® COVID-19
Amplidiag® COVID-19
Solution Novodiag® (CE-IVD)
COVID-19
C. difficile
Bacterial GE+
CarbaR+
Stool Parasites
Solution Amplidiag® (CE-IVD)
Amplidiag Easy
RESP-4
COVID-19
H. pylori+ClariR
Bacterial GE
CarbaR+VRE
CarbaR+MCR
Stool Parasites
Viral GE
C. difficile+027
LifeSciences (RUO)
S7 Fusion Polymerase™
Amplidiag® Multiplex PCR Master Mix
Nous contacter
Distributeurs Mondiaux

Articles

Mobidiag featured in Finnish magazine Taloussanomat

mars 24, 2020

This article covers Mobidiag joining the fight against coronavirus with innovative diagnostic solutions.

Read Full Article

Share on: Share on Facebook Share on Linkedin Share on Twitter

Publié dans : Entendu dans les médias

Navigation de l’article

← Development of Novodiag® assay for safe and easy molecular testing of novel coronavirus and influenza viruses

Supporting new tools to test for COVID-19: a priority for the EU and its bank →

Actualités
Publications

©2023 Hologic, Inc. All rights reserved.
Hologic, Mobidiag, Novodiag and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks, and product names are the property of their respective owners.
Learn more about our Privacy policy.

Top

Êtes vous un professionnel de santé?

Oui

Non

Vous devez être un professionnel de santé pour accéder à notre site.